Physician profile
Brian Robert Ross
NPI 1114366317
$2,311.41
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,273 · 2020: $288 · 2021: $281 · 2022: $365 · 2023: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $303.70 | 2019-2022 | |
| Viiv Healthcare Company | $233.85 | 2019-2022 | |
| Amarin Pharma, INC. | $173.95 | 2019-2020 | |
| Amgen INC. | $153.15 | 2019-2023 | Prolia |
| Novo Nordisk INC | $148.79 | 2019-2020 | |
| Fresenius USA Marketing, INC. | $142.19 | 2022 | |
| Horizon Therapeutics Plc | $131.87 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $121.35 | 2021 | |
| Sanofi-Aventis U.S. LLC | $111.07 | 2019 | |
| Pfizer INC. | $108.65 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $102.20 | 2019-2020 | |
| Gilead Sciences, INC. | $95.51 | 2019-2020 | |
| Janssen Products, LP | $71.98 | 2019 | |
| Astellas Pharma US INC | $71.36 | 2019 | |
| Lilly USA, LLC | $61.57 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $58.72 | 2019 | |
| Allergan, INC. | $57.22 | 2019-2020 | |
| Abbvie INC. | $27.82 | 2021 | |
| Eisai INC. | $17.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.29 | 2019 | |
| Shire North American Group INC | $17.13 | 2019 | |
| Abbott Laboratories | $17.08 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.18 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.75 | 2020 | |
| Janssen Biotech, INC. | $13.35 | 2020 | |
| Upsher-Smith Laboratories LLC | $13.25 | 2019 | |
| Topcon Healthcare Solutions, INC. | $10.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.